New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...

Labeling data is a time-consuming, labor-intensive and costly procedure for many artificial intelligence tasks. Deep Bayesian active learning (DBAL) boosts labeling efficiency exponentially, ...

Industry groups and drugmakers want the US Food and Drug Administration (FDA) to explicitly clarify that Bayesian statistical methods can be used for products beyond those intended for children and ...

Artificial intelligence (AI) increasingly powers safety-critical systems that demand robust, energy-efficient computation, often under conditions of data scarcity and uncertainty. Traditional AI ...